In mammalian cells, the supply of lipids is co-ordinated with demand through the transcriptional control of genes encoding proteins required for synthesis or uptake. The sterol regulatory element binding proteins (SREBPs) are responsible for increased transcription of these genes when lipid levels fall. Mammals have three SREBPs (-1a, -1c and -2), which are the products of two distinct genes. Synthesized as ~120 kDa precursors, they are inserted into membranes of the endoplasmic reticulum (ER) in a hairpin fashion. Both the N-terminal transcription factor domain and the C-terminal regulatory domain face the cytoplasm. These are connected by two transmembrane helices separated by a short loop projecting into the ER lumen. The C-terminal domain of SREBP interacts with the C-terminal domain of SREBP-cleavage-activating protein (SCAP). The N-terminal half of SCAP contains eight transmembrane helices, five of which (helices 2-6) form the sterol-sensing domain. In response to cellular demand for lipid, this complex exits the ER and transits to the Golgi apparatus, where two distinct proteases cleave the SREBP precursor to release the transcriptionally active N-terminus. This process was the first example of regulated intramembrane proteolysis for which the proteases were identified. Recent work has additionally uncovered integral membrane proteins, insig-1 and insig-2, that are required to retain the SREBP-SCAP complex in the ER in the presence of sterols, thus providing a more complete understanding of the control of proteolysis in this complex regulatory pathway.
Introduction
Until recently, few people would have considered proteolysis to be a vital mechanism for cellular signal transduction. Yet recent results, coming from a wide range of biological research, point to just such a conclusion. The most surprising examples concern proteases that cleave their substrates within transmembrane helices in a process termed regulated intramembrane proteolysis (Rip) [1] . Here I will consider in detail the role of Rip in the sterol regulatory element binding protein (SREBP) pathway controlling lipid metabolism in mammalian cells, with special consideration of recent discoveries. To place this example in context, I will briefly mention several other examples of Rip that have been discovered in the past few years.
Rip
In the best understood examples of Rip, two distinct proteases cleave their substrate sequentially to release protein fragments that activate the transcription of target genes. The first cleavage occurs in the extracytoplasmic domain of the substrate, 20-30 amino acids away from the membrane. The second cleavage, which happens only after the first cleavage has taken place, occurs within a transmembrane helix, releasing a cytoplasmic domain of the substrate.
Class 1 Rip involves substrates that are type 1 membrane proteins (i.e. Nterminus is extracytoplasmic and C-terminus is cytoplasmic). Cleavage within the transmembrane helices of these proteins requires ␥-secretase. This enzyme is a multi-component complex of integral membrane proteins that includes presenilin-1 or -2 and nicastrin, as well as other proteins (reviewed in [2] ). Interaction of ␥-secretase inhibitors with conserved aspartate residues in transmembrane helices of presenilin led to the suggestion that presenilins are aspartyl proteases [3] . Examples of class 1 Rip include signalling via the Notch receptor, processing of the receptor tyrosine kinase ErbB-4 [4] and, the most notorious example, the generation of ␤-amyloid (A␤) from amyloid precursor protein (APP). Accumulation of A␤ leads to the formation of the amyloid plaques that characterize Alzheimer's disease [5] . While A␤, the extracytoplasmic fragment of APP, has received most attention, the cytoplasmic fragment of APP appears to play a role in transcriptional activation, as observed in most other examples of Rip [6] [7] [8] .
Substrates for class 2 Rip are type 2 membrane proteins (i.e. N-terminus cytoplasmic, C-terminus extracytoplasmic), and include the SREBPs that regulate the genes of lipid synthesis [9] , as well as activating transcription factor 6␣ (ATF6␣) and ATF6␤ that mediate the transcriptional programme of the unfolded protein response [10, 11] . The former will be discussed in detail below.
Examples of both class 1 and class 2 Rip are known from invertebrates as well as mammals [12] [13] [14] [15] [16] . Rip also occurs in prokaryotes. SpoIV FB, a distant homologue of mammalian site-2 protease (S2P), is required to release the prok transcription factor from the membrane during sporulation in Bacillus subtilis [17] . In Escherichia coli, YaeL protein, another S2P homologue, cleaves the anti-factor RseA to activate a stress response dependent on E [18, 19] . In Enterococcus, Rip is required for extracellular signalling. In this organism, the S2P homologue eep cleaves its substrate within a transmembrane domain to produce active aggregation pheromone [1] .
Signal peptide peptidase (SPP)
Processing of signal peptides also employs Rip. A unique protein, SPP, cleaves the intramembrane helices that are a product of signal peptidase cleavage of secreted proteins [20] . Based on studies with protease inhibitors, SPP was predicted to be an aspartyl protease. Intriguingly, SPP shares with presenilins two conserved motifs within its transmembrane helices: a Tyr-Asp motif in helix 4 and a Leu-Gly-Leu-Gly-Asp motif in helix 5 [20] . Both of the conserved aspartates are necessary for activity in presenilin [3, 21, 22] . The two proteins are not otherwise similar; in fact, the predicted membrane orientation of the active sites in the two proteins is opposite [20] , as is the orientation of their substrates. The presence of two conserved aspartates in conserved context, each in its own transmembrane helix, strongly supports the conclusion that both SPP and the presenilins are intramembrane aspartyl proteases [3, 20] . SPP-mediated cleavage is thought to generate signalling molecules [23, 24] and may serve a general 'housekeeping' function as well.
Rhomboid
Drosophila rhomboid is an intramembrane serine protease necessary for signalling through epidermal growth factor (EGF) receptor homologues [25, 26] . This example of intramembrane proteolysis differs from the preceding examples in that intramembrane cleavage by rhomboid does not require a primary cleavage by a distinct enzyme to produce the intramembrane substrate. Rather, proteolysis by rhomboid is controlled by substrate localization [25, 26] . Rhomboid homologues are found in prokaryotes as well as in other eukaryotes, and many of these can be functionally substituted for rhomboid in mutant flies [27, 28] .
Rip and regulation of lipid metabolism
Rip has rapidly emerged as a general and ancient approach to generating signals that control diverse cellular processes [1, [29] [30] [31] . The best-studied role for Rip is in the regulation of lipid metabolism in animal cells by cleavage of SREBPs. Results reported in the past year have significantly advanced our understanding of the complex regulation of cellular lipid metabolism and the mechanisms by which proteolysis is controlled in this signalling pathway.
SREBPs and lipid metabolism
Animal cells control lipid levels primarily by regulating the transcription of the genes involved in lipid biosynthesis and uptake. Transcriptional up-regulation of these genes depends on SREBPs, a family of membrane-bound transcription factors. In mammals, there are three isoforms of SREBP, which Lipid metabolism and regulated intramembrane proteolysis of SREBPs 223
are the products of two separate genes. The isoforms have overlapping but distinct domains of transcriptional activation. While SREBP-1a and -1c preferentially activate the genes of fatty acid synthesis, SREBP-2 activates the genes of cholesterol synthesis [9] . The SREBPs are synthesized as ~120 kDa precursors that are located in the membrane of the endoplasmic reticulum (ER). They span the membrane twice, with both the N-terminal transcription factor domain and the C-terminal regulatory domain facing the cytosol. These domains are connected by two transmembrane helices that are themselves separated by a loop of about 30 amino acids projecting into the lumen of the ER (Figure 1 ). In the ER, SREBP forms a complex with SREBP-cleavage-activating protein (SCAP) via their respective C-terminal domains.
The pathway regulating SREBP cleavage and, therefore, transcriptional activation of the genes of lipid biosynthesis is best understood for cholesterol. Cholesterol is an essential structural component of mammalian membranes. When cellular supplies of cholesterol are adequate, the SREBP-SCAP complex remains in the ER; however, when demand for sterols rises, the SREBP-SCAP complex exits the ER by way of incorporation into COPII (coatomer complex) vesicles and moves to the Golgi apparatus [32] [33] [34] . Once there, SREBP undergoes two sequential proteolytic cleavages, due to the action of two distinct enzymes. As a result, the N-terminal transcription factor domain is released from the membrane and is free to translocate to the nucleus, where it binds to sterol regulatory elements in the promoter regions of target genes and mediates their increased transcription.
The crucial regulatory event in this process is the sensing of sterol levels by SCAP and the subsequent inclusion of SREBP-SCAP complexes into COPII vesicles. Movement of SREBP from the ER to the Golgi brings it into contact with the active proteases needed to complete processing. Therefore, regulation of proteolysis occurs at the level of accessibility of the substrate to the protease, rather than activation of or changes in the location of the proteases themselves. By placing the active proteases in a compartment separate from that in which the substrate resides in the absence of sterols, this system makes use of a distinctive feature of eukaryotic cells: subcellular compartmentalization by endomembrane systems. Recent work has detailed additional components of the regulatory machinery needed to complete this programme. Here I will discuss each of the components of the SREBP signalling machinery, with emphasis on those identified recently.
Components of the SREBP pathway
Site-1 protease (S1P) S1P is a membrane-anchored subtilisin-like serine protease of 1052 amino acids. The bulk of the enzyme, including the active site, is disposed in the lumen of the Golgi apparatus, with only a short, basic tail in the cytoplasm [35] . Figure 1 gives a schematic illustration of the membrane topology of components of the SREBP pathway. In common with other proteases of the secretory In the presence of adequate cellular supplies of sterols, the SCAP sterol-sensing domain interacts with insig proteins. This interaction serves to retain the SREBP-SCAP complex within the ER, preventing its movement to the Golgi apparatus. When cellular demand for cholesterol increases, the interaction between SCAP and insig is disrupted and the SREBP-SCAP complex is free to be packaged into COPII vesicles and move to the Golgi apparatus. Once there, SREBP becomes the substrate for two different proteases that act in sequence. First, S1P cleaves SREBP at site-1, in the middle of the luminal loop. S1P is a subtilisin-like protein and has residues of the classic serine protease catalytic triad (Ser, His, Asp). Cleavage by S1P separates the two halves of SREBP. The N-terminal half is then cleaved at site-2, within the transmembrane helix. This cleavage requires S2P, a hydrophobic, membrane-embedded protein with an HEXXH motif (indicated) characteristic of many metalloproteases. Also indicated is a motif, LDG, that is common to all members of the S2P family and that probably provides a additional co-ordinating ligand for the active-site metal atom. The putative metal ligand residues are shown in bold. The metal ligand motifs are separated in the linear sequence of S2P by a large, relatively hydrophilic domain containing multiple, conserved Cys residues (Cys-rich). The function of this domain is unknown. As a result of these sequential cleavages, the N-terminal basic helix-loop-helix leucine zipper transcription factor domain (bHLH-zip) of SREBP is released into the cytoplasm and translocates to the nucleus to direct the increased transcription of genes of lipid metabolism. For references, see the text. The Figure is based on membrane topology data derived from the following protease protection and glycosylation studies: SREBP [71] , SCAP [72] , S1P [35, 40] and S2P [49] . No topological data have been reported for insig-1 or -2.
pathway, S1P is synthesized in the rough ER as an inactive proenzyme. Two autocatalytic cleavages serve to render the enzyme active in the Golgi apparatus [35, 36] . In contrast with other serine proteases of the secretory pathway, S1P cleaves its substrate within a luminal domain after a hydrophobic residue rather than a basic residue, i.e. RXXL↓L rather than RX(R/K)R↓X [37, 38] , where ↓ indicates the scissile bond. S1P was isolated by an expression/complementation strategy in mutant Chinese hamster ovary cells that are auxotrophic for cholesterol (SRD-12A and -12B cells) [39, 40] . In these cells,, SREBPs are not cleaved at site 1. As a result, no nuclear SREBP is formed, and the transcription of the genes of cholesterol biosynthesis cannot be up-regulated. This result explained the auxotrophic phenotype of SRD-12 cells and confirmed the essential role of S1P in the regulation of lipid metabolism [39] .
In addition to the SREBPs, S1P also cleaves ATF6␣ at an RHLL↓G sequence within its luminal domain [41] . S1P may also have roles in the secretory pathway other than simply processing transmembrane transcription factors. At about the same time that we described the identification of S1P, the analogous enzyme from mice and rats, termed SKI-1, was isolated by virtue of its ability to cleave brain-derived neurotrophic factor [42] . Seidah and coworkers [43] found that, in some circumstances, S1P may be shed into the medium. Subsequently, Lenz et al. [44] showed that S1P is necessary for the production of infective Lassa virus particles. S1P may also cleave other viral proteins, such as Crimean-Congo haemorrhagic fever virus [45] . In mice, S1P is an essential gene; mice lacking the enzyme die as embryos [46] . Mice with a liver-specific conditional knockout of the S1P gene are viable and express only 10-30% of normal levels of S1P. In these animals, lipid synthesis and plasma cholesterol levels are reduced [46] , demonstrating that S1P is involved in the normal physiological regulation of lipid metabolism in the liver, just as observed in our studies with mutant fibroblasts [39, 40] .
S2P
S2P is a highly unusual protein of 519 amino acids that contains an HEXXH (His-Glu-Xaa-Xaa-His) motif. This sequence is characteristic of many families of metalloproteases, where the two histidines provide co-ordinating ligands for the active-site metal atom and the glutamate provides a nucleophile for hydrolysis of the scissile bond [47] . S2P is unique among metalloproteases in having the HEXXH motif within an otherwise hydrophobic stretch of amino acids [48, 49] . Analysis of mutant Chinese hamster ovary cells auxotrophic for cholesterol led to the identification and complementation cloning of S2P. In these cells, SREBP cleavage does not occur. No SREBP gets to the nucleus and transcription of cholesterol biosynthetic genes cannot be upregulated. Instead, an intermediate form of SREBP, the product of cleavage at site-1, accumulates in the membranes in the absence of sterols [50] .
Subsequent studies with site-directed mutant versions of the S2P cDNA in the S2P-null cells demonstrated that both histidines and the glutamate of the HEXXH motif are essential for proteolysis of SREBPs. An additional aspartate residue residing within the sequence LDG (Leu-Asp-Gly) is also essential for S2P function. All S2P homologues in species from prokaryotes to humans also contain both the HEXXH and ⌽DG motifs (where ⌽ is a hydrophobic amino acid, typically leucine) [1, 51] . Together, these observations support the notion that this aspartate residue provides an additional co-ordinating ligand for the active-site metal atom [49] .
Biochemical studies on the membrane topology of S2P, using protease protection and glycosylation, support a model in which both the HEXXH and LDG motifs are within the bilayer or, perhaps, just at its cytoplasmic surface. All of the hydrophilic regions of the protein are luminally disposed, whereas both the C-and N-termini are facing the cytoplasm [49] . These results are in contrast with predictions based on computational considerations [51] .
Cleavage of SREBPs by S2P rapidly follows cleavage by S1P; the intermediate product is not normally observed in wild-type cells. The same result is observed for ATF6␣ [41] . Since active S1P is located in the Golgi apparatus, active S2P is thought to reside there as well. Immunofluorescence studies with overexpressed, epitope-tagged S2P indicate a localization within the Golgi for the tagged protein [52] .
SCAP
SCAP is a 1276-amino-acid protein that comprises two domains. The Nterminal domain consists of eight transmembrane helices. Helices 2-6 comprise a sterol-sensing domain. 3-Hydroxy-3-methylglutaryl-CoA reductase, the rate-limiting enzyme of cholesterol biosynthesis, contains a similar domain, which is necessary for the sterol-modulated stability of the enzyme [53] . Similar domains are also present in two other proteins associated with cholesterol: the Niemann-Pick Type C gene product (NPC1) [54, 55] and Patched, the receptor for Hedgehog. Hedgehog is the only protein known to contain a covalently attached cholesterol moiety [56] .
Additional evidence for the important role of these transmembrane helices in transducing the signal from cellular cholesterol to SREBP cleavage comes from analysis of mutant cells resistant to the killing effects of 25-hydroxycholesterol. 25-Hydroxycholesterol is a potent suppressor of SREBP cleavage and, therefore, of the transcriptional activation of the sterol biosynthetic genes that are targets of nuclear SREBP [57] . Owing to the presence of the additional hydroxy group, 25-hydroxycholesterol cannot substitute functionally for cholesterol within the membrane bilayer. As a result, wild-type cells grown in the continual presence of 25-hydroxycholesterol starve to death, as they can neither make nor take up cholesterol, and they cannot use the sterol that is present [58] . One class of mutations that confer resistance to the killing effects of 25-hydroxycholesterol are point mutations within the sterol-sensing domain of one copy of the two SCAP genes normally expressed. Such mutations confer dominant resistance to 25-hydroxycholesterol. In fact, SCAP was cloned owing to one such dominant point mutation within the sterol-sensing domain, D443N [59] .
Subsequently, two additional sterol-insensitive mutations were mapped to the sterol-sensing domain of SCAP [60, 61] . We now know that one effect of these point mutations is to interfere with the interaction between the SCAP Lipid metabolism and regulated intramembrane proteolysis of SREBPs 227
sterol-sensing domain and other proteins. This interaction is normally required to retain SCAP in the ER in the presence of sterols (see below). Brown et al.
[62] have recently shown that the membrane-spanning helices of SCAP undergo a conformational change upon addition of cholesterol to membranes. Mutant SCAP harbouring the Y298C mutation that renders it insensitive to sterols is somewhat more resistant to this change than is wild-type SCAP. This suggests that sterol sensing by SCAP involves a conformational change within the sterol-sensing domain, and that this change may serve to block interaction between SCAP and its ER retention partner, insig (see below). The C-terminal domain of SCAP is composed of multiple WD (Trp-Asp) repeats, which are normally found in protein-interaction domains. SCAP and SREBP form a complex via their respective C-terminal domains. Formation of this complex is constitutive, occurring in both the absence and the presence of cholesterol. In the absence of complex formation, both SREBP and SCAP are much less stable than in its presence [63] .
Mutant Chinese hamster ovary cells that completely lack SCAP protein (SRD-13A cells) fail to process SREBPs and are cholesterol auxotrophs as well [63] . Similarly, mice harbouring a liver-specific knockout of the SCAP gene show profound deficits in lipid synthesis [64] . Transgenic mice carrying a SCAP allele harbouring the activating point mutation D443N further confirm the crucial role of SCAP in lipid homoeostasis in the liver. Just as observed in mutant cells, SREBP cleavage and, therefore, lipid synthesis is strongly up-regulated in the livers of these animals [65] .
Insig
In August 2002, Yang et al. [66] reported the identification of an important new component of the SREBP cleavage regulatory machinery, insig-1. Insig-1 mRNA was originally identified by Taub and co-workers [67, 68] as an mRNA that increased when rat hepatoma cells were cultured in the presence of insulin. The search for this protein was stimulated by previous work that indicated that SREBP-SCAP complexes had to interact (via the SCAP sterol-sensor domain) with another protein in the ER in order to be retained in the presence of sterols [69] . Insig-1 was identified by co-precipitating proteins that bound to membrane-spanning helices 1-6 of SCAP and identifying the coprecipitated proteins by tandem MS. Yang et al. [66] demonstrated that insig-1 is located in the ER in both the presence and the absence of sterols. They also showed that binding of SCAP and insig-1 is induced by sterols, and that overexpression of insig-1 sensitizes cells to the sterol-mediated suppression of SREBP proteolysis. These results strongly support the identification of insig as the SCAP retention factor.
Yabe et al. [70] then identified another ER retention protein for the SREBP-SCAP complex, insig-2, on the basis of its sequence identity with insig-1. Two differences between the insig proteins are that (1) while the insig-1 gene is a transcriptional target of SREBP-2, the insig-2 gene is not, and (2) insig-1 will, when expressed at sufficiently high levels, bind to SCAP even in the absence of sterols, whereas insig-2 will bind to SCAP only in the presence of sterols [66, 70] . These characteristics mean that the insig proteins add additional levels of regulatory feedback complexity to the proteolytic cleavage of SREBPs.
Interestingly, as touched on above, the three point mutations known to render SCAP insensitive to sterols, and therefore cause the constitutive proteolysis of SREBPs, also block interaction between SCAP and insig proteins [61] . An antibody against insig protein efficiently precipitates SREBP in the presence of wild-type SCAP, but in the presence of mutant SCAP (Y298C, L315F or D443N), SREBP is not precipitated with insig [61] . These results further indicate the crucial role that the SCAP-insig interaction plays in the sterol-regulated proteolytic processing of SREBPs.
The insigs are hydrophobic, integral membrane proteins [66, 70] . However, they lack any obvious ER retention signal, raising the question of how the insig proteins are themselves retained within the ER. It seems likely that other, as-yet-undiscovered, proteins may also be involved in the complex protein machinery that controls lipid metabolism in animal cells.
Conclusions
The SREBP pathway exemplifies a classic biochemical feedback mechanism. It also provides a detailed example of the way a newly appreciated strategy, Rip, can play a crucial role in vital signal transduction pathways. By controlling the movement of a substrate (SREBP) to active proteases (S1P and S2P), sterols regulate their own biosynthesis and uptake via transcriptional activation of the relevant genes. As the details of SREBP proteolysis have been worked out, similar proteolytic signalling processes have been identified in other systems, ranging from development (e.g. the Notch/␥-secretase and star/spitz/rhomboid systems) to neurodegeneration (e.g. Alzheimer's disease.) Additional examples are now known from bacterial systems (eep, SpoIV FB and YaeL) and from signal peptide processing (SPP). This list of examples is likely to continue to grow as additional examples of Rip are identified.
